Signalling Pathways 2018: Programme

The programme of the ESMO Symposium on Signalling Pathways in Cancer 2018 is now online!

Access the Signalling Pathways 2018 Online Programme

The 6th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), will focus on Cyclin-dependent kinases (CDKs).




The programme of the Symposium has been accredited with 11 Cat. 1 ESMO-MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification also guarantees that a certified medical oncologist has continued to update her/his knowledge and continue to possess the necessary skills and standards for the practice of medical oncology.  See here for further details.